BioCardia, Inc., headquartered in San Carlos, California, is developing regenerative biologic therapies to treat cardiovascular disease. CardiAMP⢠and CardiALLO⢠cell therapies are the Companyâs biotherapeutic product candidates in clinical development. The Company's current products include the Helix⢠transendocardial delivery system, the MorphÂŽ steerable guide and sheath catheter portfolio, and the new AVANCE⢠steerable introducer family. BioCardia also partners with other biotherapeutic companies to provide its Helix systems and clinical support to their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia and acute myocardial infarction.
Source
